跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INHALOK AIRMASTER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION, POLVO PARA INHALACION (UNIDOSIS) - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
INHALOK AIRMASTER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION, POLVO PARA INHALACION (UNIDOSIS)
Approved
STANDARD
INHALOK AIRMASTER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION, POLVO PARA INHALACION (UNIDOSIS)
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 23, 2021
Approval ID
e1d8bb25ab657f0d
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
e1d8bb25ab657f0d
Drug Cima Aemps Name
INHALOK AIRMASTER 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION, POLVO PARA INHALACION (UNIDOSIS)
Register Number
85847
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2021-04-23
Dosage Form
POLVO PARA INHALACIÓN (UNIDOSIS)
Dose
50 MICROGRAMOS/250 MICROGRAMOS
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
SALMETEROL XINAFOATO
0,073 mg
FLUTICASONA PROPIONATO
0,25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 23, 2021
Approval ID
e1d8bb25ab657f0d
Type
Standard
Back to CIMA-AEMPS Approvals